This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A May 2024 article in the International Journal of Molecular Sciences assesses efforts thus far using CBD to treat inflammatory pain (such as in arthritis) via transdermal delivery systems. Ultimately, they concluded that the available data on pain and other outcomes was unreliable, with a high risk of bias. So what do the studies say?
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Agriculture (IDOA), which is the lead regulator for a broad swath of the cannabis industry in Illinois and consists of three bureaus.
.” And according to a recent article in Forbes.com, e-mail mass marketers are spamming in-boxes with what purports to be a Fox News article promoting CBD oils and gummies as a novel COVID therapy.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Public Health (IDPH) portion of the report, which touts this year’s accomplishments as hiring needed staff and hosting Medical Cannabis Advisory Board (MCAB) meetings.
You might not know that after reading a recent New Yorker article that draws connection between marijuana use, schizophrenia and violent crimes in Washington. Gladwell’s article also draws on a new book by former New York Times reporter Alex Berenson called “Tell Your Children: The Truth about Marijuana, Mental Health and Violence.”.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This article focuses on the Department of Financial & Professional Regulation (IDFPR) portion of the report, which touts FY2024 as “a year of explosive growth in the cannabis industry” in Illinois.
By Oliver Bennett, Special Contributor to New Frontier Data. Read full article at [link]. Once welcomed as a progressive venue forward for adult-use legalization, Barcelona’s cannabis clubs suddenly find themselves in legal limbo, and possible jeopardy of elimination. Even the City Hall doesn’t know exactly what is going to happen.
The post Article: NSW crime data shows Cannabis Cautioning Scheme has become a ‘class war’ first appeared on Cannabis Law Report. Who’d have known ! Well done the Newcastle Herald for reporting this in such detail. One of the best pieces of cannabis journalism in … Read More.
According to data compiled by industry data and intelligence firm Hemp Benchmarks , it is the only hemp category tracked by the company that experienced price increases on a year-over-year basis in 2020. Read full article. The circuit court ordered the case back to district court.
In his first article of the new year, Raphael Mechoulam and other Israeli scientists look at the “real life experiences of medical cannabis treatment in autism.” Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs).
Childish misrepresentation” of data The memorandum was released… Read More. The post Australian Press Article Says. You know things are awry when you have clinicians saying things like.
CBE have published the following article. Read the full article at. From data-related class action concerns to security disclosures and labeling issues, cannabis companies may see themselves facing class action filings. Here are a selection of the highlights. Increasing Cannabis Class Action Risks.
The ERP operates as a system, collecting data in real time and connecting it all together for your. Since the ERP is equipped with all of the company’s information, the access to data is controlled. Since the ERP is equipped with all of the company’s information, the access to data is controlled. Access Control.
According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 billion respectively, according to a recent Forbes article. million marijuana plants and conducted more than 6,600 marijuana related arrests.
Public Broadcasting Massachusetts reports Thousands of employees in the Massachusetts cannabis industry received an official email last week about a major data breach: the name, home and email address, phone number and date of birth of every cannabis worker in the state had been made public in an “inadvertent release of agency documents” by the […] (..)
The American Association of Poison Control Centers (AAPCC) maintains the National Poison Data System (NPDS), which houses de-identified case records of self-reported information collected from callers during exposure management and poison information calls managed by the country’s poison control centers (PCCs). exposures to any substance(s).
billion by 2025, cannabis market research company New Frontier Data said. Adding to the enticement is that the global legal market for cannabis is forecast to reach $91.5 billion by 2028, according to Grand View Research. market is expected to annually grow 21% and will reach $41.5 Medical cannabis sales in the U.S. are forecast to reach $16.3
This provision is colloquially known as the “Drug Preclusion Provision.”. “…a product that contains an article that is an approved new drug or licensed biologic cannot be a dietary supplement unless the article was marketed as a dietary supplement or as a food before its approval as a new drug or licensing as a biologic.
Greg Kaufman of Eversheds Sutherland outlines the key provisions and urges lawmakers to consider data collected at the state level to get it right. This summer three U.S. On July 14, 2021, U.S. Senators Chuck Schumer (D-N.Y.), Cory Booker (D-N.J.) and Ron Wyden (D-Ore.)
Drilling down into the cannabis trademark landscape in 2018 uncovered a heavy focus on goods in Classes 34 (smokers’ articles) and 5 (medicines/pharmaceuticals), as well as Nice classes relating to food and drink products. Smokers’ articles. Smokers’ articles. TS Brandco Inc. Dutch Passion Holding BV. Edible oils.
The plan follows two reports to Congress last year (which the Perkins Coie Cannabis Industry Group has previously written about here and here ) on the safety and labeling of products containing cannabidiol (CBD) and a public statement from outgoing FDA leadership in early 2021 seeking better data for a better understanding of CBD safety.
Data shows that commercial drivers are consuming cannabis more than any other drug, even if it can ruin their career. Commercial drivers test positive for cannabis more often these days than any other drug, according to the latest data from the U.S. The data matches existing data on drivers in general.
Move as quickly as the cannabis industry, printing variable data on demand. The post Handheld inkjet printers keep cannabis companies compliant–and agile appeared first on Leafly.
This article is definitely worth a read. Read the full article at. Apart from getting DC to act it is the sector’s biggest challenge. live either in medical-only markets or states without legalized cannabis. Expanding Legalization and the Erosion of the Illicit Market.
WHILE Italy is both one of the earliest and largest medical cannabis markets in Europe, new data has revealed the ongoing inability of its system to ‘serve patients’ needs’. Read full article. The Italian Military’s Monopoly On Medical Cannabis Production Is Strangling Market Growth New Data Suggests. Undersupply.
(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.
International Hemp will begin producing the new varieties at commercial volumes with domestic seed production partners in 2022 and expects to have samples available with corresponding yield data by 2023. Read the full article at [link].
Editor’s Note: This following blog is an excerpt from an article that appeared in the March/April 2019 issue of Terpenes & Testing Magazine. View the full article. . Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. Publish to the Blockchain.
A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. It’s important to note that the Washington data was more limited than the Colorado data.
It’s common to see articles these days related to the positive economic impacts of hemp legalization. Most of these articles focus on job creation, opportunities for farmers, or opportunities for businesses chasing the CBD craze.
Arizona is on track to outpace Colorado in marijuana sales just months after it became legal for recreational use in the Copper State, with total annual sales expected to surpass $1 billion by the end of this year, according to state data. Read full article.
Look no further than the 7th paragraph of the CNN article, where the lead author of the study is quoted as saying that the study “did not research how cannabis affects heart health.”. of non-users who experienced heart attacks was small enough to be “within the margin of error for nearly any survey or polling data.”
In addition to the array of legal and regulatory concerns about the sale of Hemp CBD products in the EU noted in our above-linked post, the EU’s General Data Protection Regulation (“GDPR”) is something that almost any U.S.-based The GDPR is a groundbreaking EU privacy and data security regulation that went into effect on May 25, 2018.
Worth a read and features an interview with Global Cannabis Top 200 lawyer Eveline Van Keymeulen When compiling a list of the types of expert involved in the innovations that are changing our world, you might write: data-whizz, researcher, and entrepreneur. Lawyer’ would probably not be the first to come to mind. But behind many […].
Headset , a data platform for the cannabis economy, recently released a report that examined the Illinois cannabis market. According to Headset, “This report analyzes detailed data on thousands of products in the Illinois market to determine how it compares to other states. EQ price is the price per gram for inhalable products.
Interesting article that uses Qld’s seat of Dickson as an example of the sea-change in attitude toward cannabis use in formally conservative parts of Australia. Read the full article. Dickson is currently held by the leader of the opposition, arch – conservative and ex police sgt, Peter Dutton.
As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data. Other strategies include filing patents on synthetic pathways, extraction protocols, novel formulations, methods of use, and methods of treatment in various disease conditions.
This article by Cannabiz takes a look at what’s happening and suggests some solutions. According to data from Cannabiz Intelligence™ , a handful of cannabis license holders dominate multiple markets across the United States. Read full article at. Here’s a snippet.
First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. The authors note, however, that the data doesn’t include patient outcomes.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content